{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"1.9","upperLimit":"4.7","value":"3.3"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"12"}],"units":"Participants"}],"description":"Pharmacokinetic assay- tmax, hr\n\nSamples drawn at 5 timepoints: (0 (pre dose), 30min, 1 hour, 3 hours, and 6 hours post-dose) on two different days","dispersionType":"90% Confidence Interval","groups":[{"description":"Includes study subjects from either stratum that signed an optional consent to have PK's collected","id":"OG000","title":"Study Subjects Consented to PK Collection"}],"paramType":"MEAN","populationDescription":"12 subjects from both Stratum 1 and 2 were analyzed together as one group as per statistical analysis plan.","reportingStatus":"POSTED","timeFrame":"0 (pre dose), 30min, 1 hour, 3 hours, and 6 hours post-dose on two different days","title":"Time to Reach Peak Plasma Concentration (Tmax)","type":"SECONDARY","unitOfMeasure":"hours"}